Efficacy and Safety of Ivabradine Once-Daily Prolonged-Release versus Twice-Daily Immediate-Release Formulation in Patients with Stable Chronic Heart Failure with Systolic Dysfunction: ARandomized, Double-Blind, Phase 3 Non Inferiority (PROFICIENT) Study